Actionable news
0
All posts from Actionable news
Actionable news in CVS: CVS HEALTH CORPORATION,

Successful Acquisitions, Specialty Business Growth Raise Prospects for CVS

Jefferies analysts upped their price target on CVS Health (CVS) to $122 from $110 and maintained their buy rating on the stock after attending investor meetings with CVS' chief accounting officer.

"Recent acquisitions are on track, CVS' Specialty business continues to outpace the industry, and in Retail, we see a shift favoring Rx over the front-end," wrote analyst Mark Wiltamuth in a May 12 note.

Woonsocket, R.I.-based CVS in December completed its purchase of Target's (TGT) pharmacy and clinic businesses for about $1.9 billion. As...


More